Metastatic Mechanisms of Uveal Melanoma – the Zimmerman Effect by Hans Grossniklaus, MD

Progress in Treatment of Metastatic Uveal MelanomaПодробнее

Dr Hans Grossniklaus - Ocular OncologyПодробнее

Evolution Uveal MelanomaПодробнее

Ask the Expert - Liver Directed Therapies for Metastatic Uveal MelanomaПодробнее

A Potential Molecular Target for the Treatment of Uveal MelanomaПодробнее

Metastatic Uveal Melanoma VideoПодробнее

AANP Teaching Rounds - January 23, 2023 - Ocular Pathology: Uveal melanoma, Retinoblastoma, CataractПодробнее

Dr Hans Grossniklaus Eyes on a Cure Symposium SPORE Part 1Подробнее

Systemic Therapy for Metastatic Ocular MelanomaПодробнее

Liver-directed therapy for metastatic uveal MelanomaПодробнее

Liver Directed TherapiesПодробнее

Question and Answer with Caroline Craven and Dr Hans GrossniklausПодробнее

First FDA Approval for Metastatic Uveal Melanoma: What it Means for the OM CommunityПодробнее

Using Immunoembolization and Ipilmumab to treat Uveal MelanomaПодробнее

DNA-based analysis identifies risk factor for metastasis of uveal melanomaПодробнее

Question and Answer with Dr Bergstrom, Wells, GrossinklausПодробнее

Endoresection uveal melanoma TTS type IПодробнее

Advanced (Unresectable or Metastatic) Melanoma – Why Mutations MatterПодробнее

Oncogenic mutational profiling 1 Uveal melanomaПодробнее